´
1869
M. Koszytkowska-Stawinska et al. / Tetrahedron Letters 52 (2011) 1866–1870
18. Koszytkowska-Stawin´ ska, M.; Sas, W.; Sowin´ ska, A. J. Chem. Res. (S) 1996, 162.
19. (a) Clément, J.-L.; Finet, J.-P.; Fréjaville, C.; Tordo, P. Org. Biomol. Chem. 2003, 1,
1591; (b) Bardelang, D.; RockenBaure, A.; Karoui, H.; Finet, J.-P.; Biskupska, I.;
Banaszak, K.; Tordo, P. Org. Biomol. Chem. 2006, 4, 2874; (c) Stolze, K.; Rohr-
Udilova, N.; Hofinger, A.; Rosenau, T. Bioorg. Med. Chem. 2008, 16, 8082.
20. For a very detailed review on the preparation and reactivity of nitrones, see:
Ref. 15c.
Acknowledgments
This work was financed by the Ministry of Science and Higher
Education, Poland; projects 3 T09A 130 15, 1 T09B 013 30.
References
21. Barbati, S.; Clément, J.-L.; Fréjaville, C.; Bouteiler, J. C.; Tordo, P.; Michel, J. M.;
Yadan, J. C. Synthesis 1999, 2036.
22. 3-[2-(1,3-Dithian-2-yl)ethyl]-3-nitro-1,5-dioxaspiro[5.5]undecane (7). BF3ꢀEt2O
1. Charette, M.; Gray, M. W. IUBMB Life 2000, 49, 341.
(0.70 mL, 5.5 mmol) was added to
a cold (0 °C) mixture of 5 (775 mg,
2. (a) Yoshikawa, T.; Kimura, S.; Hatano, T.; Okamoto, K.; Hayatsu, H.; Arimoto-
Kobayshi, S. Food Chem. Toxicol. 2002, 40, 1165; (b) Monobe, M.; Arimoto-
Kobayashi, S.; Ando, K. Mutat. Res. 2003, 538, 93.
3.2 mmol), HS(CH2)3SH (0.46 mL, 4.6 mmol) and dry CH2Cl2 (50 mL). After
stirring for 2 h at room temperature, CH2Cl2 (50 mL) was added. The mixture
was washed with NaOH aq (5%, 20 mL), H2O (10 mL), brine (10 mL) and dried
(MgSO4). The volatiles were removed by distillation. Column chromatography
of the residue (hexane/AcOEt, 3/1, v/v) gave 7 (775 mg, 70%) as a white solid
(mp 124–128 °C). dH (CDCl3, 200 MHz) 1.34–1.93 (13H, m), 1.97–2.17 (3H, m),
3. (a) Yokoyama, M.; Ikeue, T.; Ochiai, Y.; Momotake, A.; Yamaguchi, K.; Togo, H. J.
Chem. Soc., Perkin Trans. 1 1998, 2185; (b) Momotake, A.; Togo, H.; Yokoyama,
M. J. Chem. Soc., Perkin Trans. 1 1999, 1193; (c) Yokoyama, M.; Ikenogami, T.;
Togo, H. J. Chem. Soc., Perkin Trans. 1 2000, 2067; (d) Häberli, A.; Leumann, C. J.
Org. Lett. 2001, 3, 489; (e) Häberli, A.; Leumann, C. J. Org. Lett. 2002, 4, 3275; (f)
Häberli, A.; Mayer, A.; Leumann, C. J. Nucleosides, Nucleotides Nucleic Acids 2003,
22, 1187; (g) Marczak, R.; Hoang, V. T.; Noworyta, K.; Zandler, M. E.; Kutner, W.;
D’Souza, F. J. Mater. Chem. 2002, 12, 2123; (h) D’Souza, F.; Gadde, S.; Islam, D. M.
S.; Pang, S. C.; Schumacher, A. L.; Zandler, M. E.; Horie, R.; Araki, Y.; Ito, O. Chem.
Commun. 2007, 480; (i) Sørensen, M. D.; Khalifa, N. M.; Pedersen, E. B. Synthesis
1999, 1937; (j) Filichev, V. V.; Pedersen, E. B. Tetrahedron 2001, 57, 9163; (k)
Kim, D. C.; Yoo, K. H.; Kim, D. J.; Chung, B. Y.; Park, S. W. Tetrahedron Lett. 1999,
40, 4825; (l) Romero, F. A.; Du, W.; Hwang, I.; Rayl, T. J.; Kimball, F. S.; Leung, D.;
Hoover, H. S.; Apodaca, R. L.; Breitenbucher, J. G.; Cravatt, B. F.; Boger, D. L. J.
Med. Chem. 2007, 50, 1058; (m) Coutouli-Argyropoulou, E.; Lianis, P.; Mitakou,
M.; Giannoulis, A.; Nowak, J. Tetrahedron 2006, 62, 1494; (n) Chiacchio, U.;
Corsaro, A.; Mates, J.; Merino, P.; Piperno, A.; Rescifina, A.; Romeo, G.; Romeo,
R.; Tejero, T. Tetrahedron 2003, 59, 4733; (o) Mertes, M. P.; Patel, N. R. J. Med.
Chem. 1966, 9, 868; (p) Inaba, A.; Inami, K.; Kimoto, Y.; Yanada, R.; Miwa, Y.;
Taga, T.; Bessho, K. Chem. Pharm. Bull. 1995, 43, 1601; (q) Fish, P. V.; Allan, G. A.;
Bailey, S.; Blagg, J.; Butt, R.; Collis, M. G.; Greiling, D.; James, K.; Kendall, J.;
McElroy, A.; McCleverty, D.; Reed, C.; Webster, R.; Whitlock, G. A. J. Med. Chem.
2007, 50, 3442.
4. Bailey, N.; Bamford, M. J.; Brissy, D.; Brookfield, J.; Demont, E.; Elliott, R.;
Garton, N.; Farre-Gutierrez, I.; Hayhow, T.; Hutley, G.; Naylor, A.; Panchal, T. A.;
Seow, H.-X.; Spalding, D.; Tale, A. Bioorg. Med. Chem. Lett. 2009, 19, 3602.
5. (a) Davies, M. J. In Electron Paramagnetic Resonance; Gilbert, B. C., Davies, M. J.,
Murphy, D. M., Eds.; The Royal Society of Chemistry, 2002; Vol. 18, pp 47–73;
(b) Fréjaville, C.; Karoui, H.; Tuccio, B.; Le Moigne, F.; Culcasi, M.; Pietri, S.;
Lauricella, R.; Tordo, P. J. Med. Chem. 1995, 38, 258; (c) Zhao, H.; Joseph, J.; Fales,
H. M.; Sokoloski, E. A.; Levine, R. L.; Vasquez-Vivar, J.; Kalyanaraman, B. PNAS
2005, 102, 5727; (d) Zhang, H.; Joseph, J.; Vasquez-Vivar, J.; Karoui, H.;
Nsanzumuhire, C.; Martásek, P.; Tordo, P.; Kalyanaraman, B. FEBS Lett. 2000,
473, 58.
2
2.80–2.86 (4H, m), 3.89–3.96 (3H, m), 4.48 (2H, part of an AB quartet, JAB
12.8); dC (CDCl3, 50 MHz) 22.50, 22.62, 25.52, 25.75, 28.67, 29.35, 30.10, 31.33,
35.10, 46.41, 63.28, 86.11, 99.33; mmax (KBr) 2921, 2853, 1539, 1438, 1340,
1283, 1108, 941, 908; HRMS (EI, 70 eV) m/z calcd for C15H25NO4NaS2 [M]+
370.1117, found 370.1121.
23. (a) Lhassani, M.; Chavignon, O.; Chezal, J. M.; Teulade, J. C.; Chapat, J. P.; Snoeck,
R.; Andrei, G.; Balzarini, J.; De Clercq, E.; Gueiffier, A. Eur. J. Med. Chem. 1999, 34,
271; (b) Kadota, I.; Takamura, H.; Sato, K.; Ohno, A.; Matsuda, K.; Satake, M.;
Yamamoto, Y. J. Am. Chem. Soc. 2003, 125, 11893.
24. 1-Aza-7,14-dioxadispiro[4.2.5.2]pentadec-1-ene 1-oxide (3).
A
mixture of
aluminium foil (Roth GmbH; 1.5 g, 57.5 mmol), dry THF (100 mL) and HgCl2
(1.5 g, 6.0 mmol) was stirred at room temperature for 10 min under argon. A
solution of 7 (1.0 g, 2.9 mmol) in a THF/H2O mixture (50 mL/2 mL) was added
dropwise. The reaction mixture was stirred at room temperature until 7 was
not detected by TLC (hexane/AcOEt, 3/1, v/v), ca. 2 h, and then filtered through
a
CeliteÒ pad. The filtrate was concentrated to dryness and the residue
(810 mg) dissolved in MeCN (250 mL). NaHCO3 aq (saturated, 40 mL) and MeI
(16.2 mL, 0.24 mol) were added. The mixture was stirred at 45 °C for 2 h,
cooled to room temperature and diluted with CH2Cl2 (300 mL). The mixture
was washed with H2O (80 mL), brine (80 mL) and dried (MgSO4). The volatiles
were removed by distillation. Crystallization of the residue (hexane/AcOEt)
gave 3 (485 mg, 75%) as a white solid (mp 124–126 °C). The NMR spectra were
consistent with those described in Ref. 18.
25. (a) Langley, B. W. J. Am. Chem. Soc. 1956, 78, 2136; (b) Whale, R. F.; Coe, P. L.;
Walker, R. T. Nucleosides Nucleotides 1992, 11, 1425.
26. (a) Bruni, P.; Giorgioni, E.; Tommasi, G.; Greci, L. Tetrahedron 1998, 54, 5305;
(b) Marco, J. A.; Carda, M.; Murga, J.; Portolés, R.; Falomir, E.; Lex, J. Tetrahedron
Lett. 1998, 39, 3237.
27. (a) Bonnett, R.; Brown, R. F. C.; Clark, V. M.; Sutherland, I. O.; Todd, A. J. Chem.
Soc. 1959, 2094; (b) Lee, T. D.; Keana, J. F. W. J. Org. Chem. 1978, 43, 4226; (c)
Keana, J. F. W.; Seyedrezai, S. E.; Gaughan, G. J. Org. Chem. 1983, 48, 2644; (d)
Bárácz, N. M.; Hankowszky, O. P.; Sár, C. P.; Jerkovich, G.; Hideg, K. Synthesis
1996, 204.
6. Stolze, K.; Rohr-Udilova, N.; Hofinger, A.; Rosenau, T. Bioorg. Med. Chem. 2009,
17, 7572.
7. (a) Floyd, R. A.; Hensley, K.; Forster, M. J.; Kelleher-Anderson, J. A.; Wood, P. L.
Ann. N.Y. Acad. Sci. 2002, 959, 321; (b) Maples, K. R.; Green, A. R.; Floyd, R. A. CNS
Drugs 2004, 18, 1071; (c) Floyd, R. A.; Kopke, R. D.; Choi, C.-H.; Foster, S. B.;
Doblas, S.; Towner, A. T. Free Radical Biol. Med. 2008, 45, 1361; (d) Sun, Y.; Jiang,
J.; Zhang, Z.; Yu, P.; Wang, L.; Xu, C.; Liu, W.; Wang, Y. Bioorg. Med. Chem. 2008,
16, 8868; (e) Piccinini, F.; Bradamante, S.; Monti, L.; Zhang, Y.-K.; Janzen, E. G.
Free Radical Res. 1995, 23, 81.
28. 2,20-Bi(7,14-dioxa-1-aza-dispiro[4.2.5.2]pentadec-1-ene) 1,10-dioxide (9) and 2-
(2,4-dimethoxypyrimidin-5-yl)-7,14-dioxa-1-azadispiro[4.2.5.2]pentadec-1-ene 1-
oxide (11). t-BuLi (Aldrich; 1.7 M soln in pentane, 1.1 mL) was added to a
mixture of 8 (Aldrich; 200 mg, 0.9 mmol) and dry THF (2 mL) at ꢁ78 °C under
argon. The mixture was left at ꢁ78 °C for 30 min and then compound 3
(190 mg, 0.8 mmol) was added. The mixture was allowed to warm to room
temperature. The reaction was followed by TLC (CHCl3/acetone, 85/15, v/v) at
30 min intervals. After stirring for 3 h at room temperature, when 3 was no
longer detected by TLC, Et2O (20 mL) was added. The mixture was washed with
H2O (5 mL) and evaporated to dryness. The residue was dissolved in 1,4-
dioxane (6 mL) and CH2Cl2 (2 mL). Cu(OAc)2 (40 mg), NH3 (aq) (0.3 mL) and
H2O (1 mL) were added. The mixture was stirred at room temperature for 1 d.
The organic layer was separated, washed with H2O (10 mL), dried (MgSO4) and
concentrated to dryness. Column chromatography of the residue (CHCl3/
acetone, 85/15, v/v) gave 9 (70 mg, 39%), 10 (89 mg, 71%), and 11 (50 mg, 17%).
9: A white solid (mp >180 °C, dec). dH (CDCl3, 200 MHz) 1.43–1.56 (16H, m),
8. McGee, S. A.; Wiggins, S. A.; Pierce, J. D. Int. J. Adv. Nurs. Pract. 2003, 6, 1523–
6064.
9. (a) Krishna, M. C.; DeGraff, W.; Hankovszky, O. H.; Sár, C. P.; Kálai, T.; Jeckö, J.;
Russo, A.; Mitchell, J. B.; Hideg, K. J. Med. Chem. 1998, 41, 3477; (b) Gadajeva, V.;
Lazarova, G.; Zheleva, A. Toxicol. Lett. 2003, 144, 289; (c) Jin, Y.; Chen, S.-W.;
Tian, X. Bioorg. Med. Chem. 2006, 14, 3062; (d) Zhang, J.-Q.; Zhang, Z.-W.; Hui,
L.; Chen, S.-W.; Tian, X. Bioorg. Med. Chem. Lett. 2010, 20, 983.
10. Goldstein, S.; Lestage, P. Curr. Med. Chem. 2000, 7, 1255.
11. Giner-Sonolla, A.; Zimmerman, I.; Beudich, A. J. Am. Chem. Soc. 1959, 81, 2515.
12. Tronchet, J. M. J.; Benhamza, R.; Dolatshashi, N.; Geoffroy, M.; Türler, H.
Nucleosides Nucleotides 1988, 7, 249.
2
1.90 (4H, m), 2.35 (4H, m), 3.29 (4H, m), 3.56 and 4.34 (8H, AB quartet, JAB
11.4 Hz); dC (CDCl3, 50 MHz) 22.34, 22.58, 25.42, 26.16, 27.48, 28.49, 36.98,
64.28, 66.43, 72.57, 98.80, 136.38; mmax (KBr) 2936, 2860, 1496, 1448, 1380,
1240, 1156, 1044, 920; HRMS (EI, 70 eV) m/z calcd for
13. Maurel, V.; Rabant, J.-L.; Gambarelli, S. Rapid Commun. Mass Spectrom. 2006, 20,
2235.
14. (a) Tronche, C.; Goodman, B. K.; Greenberg, M. M. Chem. Biol. 1998, 5, 263; (b)
Chatgilialoglu, C.; Ferreri, C.; Bazzanini, R.; Guerra, M.; Choi, S.-Y.; Emanuel, C.
J.; Horner, J. H.; Newcomb, M. J. Am. Chem. Soc. 2000, 122, 9525.
C
24H36O6N2 (M+)
448.2573, found 448.2557. 11: A white solid (mp 151–152 °C). dH (CDCl3,
200 MHz) 1.34–1.84 (8H, m), 2.1 (2H, m), 2.39 (2H, m), 3.12 (2H, m), 3.63 and
2
4.57 (4H, AB quartet, JAB 11.4), 4.00 (3H, s), 4.02 (3H, s), 10.09 (1H, s); dC
15. (a) Merino, P.; Franco, S.; Merchan, F. L.; Tejero, T. Synlett 2000, 442; (b)
Lombardo, M.; Trombini, C. Synthesis 2000, 759; (c) Grigor’ev, I. A. In Nitrile
Oxides, Nitrones and Nitronates in Organic Synthesis: Novel Strategies in Synthesis;
Feuer, H., Ed., 2nd ed.; John Wiley & Sons, Inc., 2008; pp 129–434.
16. (a) Murahashi, S.-I.; Mitsui, H.; Shiota, T.; Tsuda, T.; Watanabe, S. J. Org. Chem.
1990, 55, 1736; (b) Holzapfel, C. W.; Crous, R. Heterocycles 1998, 48, 1337; (c)
Merino, P.; Revuelta, J.; Tejero, T.; Cicchi, S.; Goti, A. Eur. J. Org. Chem. 2004, 776.
17. (a) Shapiro, R.; Chambers, R. W. J. Am. Chem. Soc. 1961, 83, 3920; (b) Asbun, W.;
Binkley, S. B. J. Org. Chem. 1966, 31, 2215; (c) Asbun, W.; Binkley, S. B. J. Org.
Chem. 1968, 31, 140; (d) Lerch, U.; Burdon, M. G.; Mofatt, J. G. J. Org. Chem.
1971, 36, 1507; (e) Bridges, S. D.; Brown, D. M.; Ogden, R. C. J. Chem. Soc., Chem.
Commun. 1977, 460; (f) Brown, D. M.; Ogden, R. C. J. Chem. Soc., Perkin Trans. 1
1981, 723; (g) Grohar, P. J.; Chow, C. S. Tetrahedron Lett. 1999, 40, 2049; (h)
Hanessian, S.; Machaalani, R. Tetrahedron Lett. 2003, 44, 8321.
(CDCl3, 50 MHz) 22.39, 22.67, 25.49, 27.42, 28.21, 28.84, 37.29, 54.21, 55.19,
64.36, 72.23, 98.77, 105.98, 136.72, 159.26, 165.04, 167.74; mmax (KBr) 2948,
2936, 1716, 1688, 1556, 1536, 1480, 1464, 1356, 1252, 1244, 1108; HRMS (EI,
70 eV) m/z calcd for C18H25O5N3 (M+) 363.1794, found 363.1812. The NMR
spectra of 10 were consistent with those described: Pelissier, H.; Rodriguez, J.;
Volhardt, K. P. C. Chem. Eur. J. 1999, 5, 3549.
29. (a) Brown, R. F. C.; Clark, V. M.; Lamchen, M.; Todd, A. J. Chem. Soc. 1959, 2116;
(b) Brown, R. F. C.; Clark, V. M.; Todd, A. J. Chem. Soc. 1965, 2337; (c) Boocock, D.
G.; Darcey, B. R.; Ullman, E. F. J. Am. Chem. Soc. 1968, 90, 5945; (d) Voinov, M.
A.; Grigor’ev, I. A.; Volodarsky, L. B. Heterocycl. Commun. 1998, 4, 261.
30. Voinov, M. A.; Grigor’ev, I. A. Russ. Chem. Bull. Int. Ed. 2002, 51, 279.
31. For generation of the 2,4-dimethoxypyrimidine-Grignard reagent by halogen-
metal exchange, see Ref. 3b.